首页> 外文期刊>Critical reviews in clinical laboratory sciences >Intestinal bacteria and inflammatory bowel disease.
【24h】

Intestinal bacteria and inflammatory bowel disease.

机译:肠道细菌和炎症性肠病。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Crohn's disease (CD) and ulcerative colitis (UC) are the two principal forms of inflammatory bowel disease (IBD). Animal studies show that bacteria are involved in the etiology of IBD, and much is now known about the inflammatory processes associated with CD and UC, as well as the underlying genetic, environmental, and lifestyle issues that can affect an individual's predisposition to these diseases. However, while a number of candidate microorganisms have been put forward as causative factors in IBD, the primary etiologic agents are unknown. This review discusses the potential role of luminal and mucosal microbial communities in the etiology of IBD, and outlines studies that have been made using a variety of biotherapeutic therapies, involving the use of antibiotics, probiotics, prebiotics, and synbiotics.
机译:克罗恩病(CD)和溃疡性结肠炎(UC)是炎性肠病(IBD)的两种主要形式。动物研究表明,细菌参与了IBD的病因学,现在人们对与CD和UC相关的炎症过程以及可能影响个人对这些疾病的易感性的潜在遗传,环境和生活方式问题了解很多。然而,尽管已经提出了许多候选微生物作为IBD的致病因素,但主要的病原体还是未知的。这篇综述讨论了腔内和粘膜微生物群落在IBD病因中的潜在作用,并概述了使用多种生物疗法进行的研究,包括使用抗生素,益生菌,益生元和合生元。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号